Bayer`s Kerendia Succeeds in Phase 3 Trial for Type 1 Diabetes
06 Nov 2025 //
BUSINESS WIRE
Renalys Completes Phase III Trial Data Collection For Sparsentan
10 Oct 2025 //
PR NEWSWIRE
J&J’s Invokana closes on diabetic kidney disease approval
22 May 2019 //
PHARMAPHORUM

Market Place
Sourcing Support